165 related articles for article (PubMed ID: 34819634)
1. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
4. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis.
Li J; Yang J; Chen Z; Liu L; Wang H; Deng Q; Chen Y; Que Y; Fu Z
Biomol Biomed; 2023 May; 23(3):483-495. PubMed ID: 36373629
[TBL] [Abstract][Full Text] [Related]
5. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m
Ren M; Pan H; Zhou X; Yu M; Ji F
J Transl Med; 2024 Jun; 22(1):584. PubMed ID: 38902717
[TBL] [Abstract][Full Text] [Related]
7. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
8. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Cheng X; Li M; Rao X; Zhang W; Li X; Wang L; Huang G
Onco Targets Ther; 2019; 12():3421-3428. PubMed ID: 31118692
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
[TBL] [Abstract][Full Text] [Related]
10. m
Zhou Y; Pei Z; Maimaiti A; Zheng L; Zhu Z; Tian M; Zhou Z; Tan F; Pei Q; Li Y; Liu W
Cell Death Discov; 2022 Feb; 8(1):83. PubMed ID: 35217651
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.
Gan L; Zhao S; Gao Y; Qi Y; Su M; Wang A; Cai H
Biol Direct; 2023 Oct; 18(1):64. PubMed ID: 37807062
[TBL] [Abstract][Full Text] [Related]
12. N
Li Y; He L; Wang Y; Tan Y; Zhang F
Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
[TBL] [Abstract][Full Text] [Related]
13. lncRNA POU6F2-AS1 Regulated by KIAA1429 Contributes to Colorectal Cancer Progression in an m
Lu D; Chen A
Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38103097
[TBL] [Abstract][Full Text] [Related]
14. KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification.
Zhang Z; Guo J; Gong C; Wu S; Sun Y
Cancer Biomark; 2024 Feb; ():. PubMed ID: 38427468
[TBL] [Abstract][Full Text] [Related]
15. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
16. KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2.
Wu L; Zhou Y; Fu J
Crit Rev Immunol; 2023; 43(4):15-27. PubMed ID: 37830191
[TBL] [Abstract][Full Text] [Related]
17. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
18. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
19. SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.
Zhang X; Dai XY; Qian JY; Xu F; Wang ZW; Xia T; Zhou XJ; Li XX; Shi L; Wei JF; Ding Q
Mol Ther Nucleic Acids; 2022 Mar; 27():133-146. PubMed ID: 34976433
[TBL] [Abstract][Full Text] [Related]
20. The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer.
Liu T; Tang W; Chen Y; Liu Y; Xu D; Jiang Y; Zhou S; Qin X; Ren L; Chang W; Xu J
Clin Med Insights Oncol; 2022; 16():11795549221104441. PubMed ID: 35898390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
